‘Easy Five’, is a vaccine, which combats five infections diseases of early childhood.

Biotechnology firm Panacea Biotec has secured Rs 143 crore-contract from the United Nations Children’s Fund (UNICEF) for supplying this vaccine.  

Panacea Biotec is the first Indian pharmaceutical company to get this order from UNICEF for its vaccines in fully liquid form, the company informed the Bombay Stock Exchange.  

The order starts in 2008 and would continue till 2009.

Ahmedabad-based pharmaceutical major, Cadila Healthcare Ltd (Zydus Cadila), has entered into an agreement with the World Health Organisation (WHO) to explore a possible collaboration in the development of a drug for the treatment of rabies, through the use of monoclonal antibodies.

Sharon Bio-Medici

Aurobindo Pharma, one of the leading drugmakers in India, has informed that it has received final approval from the US Food and Drug Administration (US FDA) for its Cefazolin injection in the strengths of 500 mg and 1 gram per vial.

According to the company, the injection is a Sterile Cephalosporin product under the anti-infective segment and is a generic equivalent to Abraxis Pharmaceutical Products' reference listed drug Cefazolin.

Aurobindo has 74 abbreviated new drug applications (ANDA) approved by the U. S. FDA.